Lena Böff

Lena Böff

Auto-generated profile, based on publicly available information

Lena Böff

Robert Koch Institute, Berlin, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2025 in Eurosurveillance
Verified
Journal Article
Open access
VBVivien Brait
Vivien Brait
LBLena Böff
Lena Böff
NZNatalia Marta Zmarlak-Feher
Natalia Marta Zmarlak-Feher
NSNathalie Jourdan-Da Silva
Nathalie Jourdan-Da Silva
SMSara Mazzilli
Sara Mazzilli
MPMichael Pietsch
Michael Pietsch
Notifications of Salmonella Strathcona infections increased in Europe in 2023 prompting a multi-country outbreak investigation. We aimed to describe the epidemiology of S . Strathcona infections in 17 European countries 2011–2024, investigate the genetic relatedness of S . Strathcona isolates and identify the vehicle. Cases were persons residing in the study area and with a laboratory-confirmed S . Strathcona infection 2011–2024. Confirmed cases had a S . Strathcona isolate clustering with the outbreak reference strain in core genome multilocus sequence typing (cgMLST) within 7 allelic differences (AD) and possible cases within 8–13 AD. Probable cases had an epidemiological link to a confirmed case and non-outbreak cases had an isolate > 13 AD from the outbreak reference strain. Since 2011, 662 S . Strathcona infections have been identified: 469 confirmed, 161 probable, 13 possible and 19 non-outbreak cases. Median age of the cases was 34 years (IQR: 19–58 years) and 306 (47.5%) were notified in 2023–2024. Most sequenced isolates (469/496; 94.5%) were highly genetically related (≤ 7 AD) over time and across countries, compatible with a common source. Epidemiological and traceback investigations identified small tomatoes from Sicily as the suspect food vehicle. Stringent control measures at the source are needed to stop the contamination and prevent future cases.

4 September 2026 in BMJ Open
Verified
Journal Article
Open access
PDF file
LBLena Böff
Lena Böff
KMKouassi Julien Momou
Kouassi Julien Momou
JRJean Florent Rafamatanantsoa
Jean Florent Rafamatanantsoa
FMFrancis Mosala
Francis Mosala
FRFelix Reichert
Felix Reichert
CBCharbel El Bcheraoui
Charbel El Bcheraoui
Objectives: To assess the implementation of infection prevention and control (IPC) measures and associated factors in healthcare in low-resource settings during the COVID-19 pandemic. Design: Multinational cross-sectional study. Setting: The study was conducted from February to November 2022 in Côte d’Ivoire, Democratic Republic of Congo, Madagascar and Nigeria. Participants: A total of 6749 healthcare workers (HCWs) at 324 healthcare facilities (HCFs) were enrolled from different levels of care and types. Primary and secondary outcomes: Standardised HCW and HCF questionnaires assessed COVID-19-related exposures and IPC measures and descriptive analyses were conducted overall and by country and HCF. Partial proportional odds models were used to assess factors associated with HCW compliance to hand hygiene and mask wearing. Results: Among 324 HCFs, the reported presence of IPC programmes ranged from 51.4% (n=111) at primary non-hospitals to 83.3% (n=18) at tertiary HCFs. More than half reported no patient or HCW screening (57.4%, n=186). Only 19.8% (n=64) reported handrub at point of care in every room. Among 6749 enrolled HCWs, 54.0% were working in high-risk patient care. More HCWs reported sufficient availability of masks (62.7%, n=4231) compared with respirators (28.5%, n=1926). HCW compliance with hand hygiene and mask wearing, respectively, was improved by presence of an IPC programme (OR: 1.3, 95% CI 1.2 to 1.5; OR: 1.4, 95% CI 1.2 to 1.6), IPC training received by the HCW (OR: 1.5, 95% CI 1.3 to 1.7; OR: 1.3, 95% CI 1.2 to 1.5) and availability of handrub and masks, respectively (OR: 5.9, 95% CI 4.1 to 8.4; OR: 2.3, 95% CI 2.0 to 2.7). Conclusions: We conducted a large survey including HCFs across levels of care and type in urban and rural regions in sub-Saharan Africa. Critical gaps in IPC programmes and access to IPC equipment during the COVID-19 pandemic hindered HCW compliance with recommended IPC practices. To improve general infection control and pandemic preparedness in low-resource settings, continued focus on strengthening IPC programmes and ensuring access to materials/equipment is essential.

27 August 2026 in Eurosurveillance
Verified
Journal Article
Open access
LBLena Böff
Lena Böff
KKKathleen Klaper
Kathleen Klaper
ADAchim Dörre
Achim Dörre
APAnnemarie Pantke
Annemarie Pantke
SBSusanne Buder
Susanne Buder
TGthe Go-Surv-AMR study group
the Go-Surv-AMR study group
BACKGROUND: Neisseria gonorrhoeae (NG), the pathogen causing the sexually transmitted infection (STI) gonorrhoea, shows increasing antimicrobial resistance threatening recommended treatments. AIM: We examined temporal trends in antibiotic susceptibility of NG isolates in Germany and possible shifts in sexual networks. METHODS: We analysed annual data from the German antimicrobial resistance sentinel surveillance programme Go-Surv-AMR (2014–2023). Isolates were tested by E-test for phenotypic susceptibility to azithromycin (AZM), ceftriaxone (CRO) and ciprofloxacin (CIP) to determine minimum inhibitory concentrations (MIC). We described patient demographics and calculated MIC metrics by year, sex, age group and specimen type. We assessed differences in yearly MIC distributions using Kolmogorov-Smirnov tests and analysed temporal trends by fitting beta distributions to log-transformed MIC by antibiotic and epidemiological group. RESULTS: We collected 5,421 NG isolates from across Germany, primarily from males (n = 4,704) and from urethral specimens (n = 4,060). From 2016 to 2023, median AZM MIC nearly quadrupled in female and male isolates (0.12–0.45 mg/L). Median CRO MIC remained low overall (≤ 0.009 mg/L) but increased significantly in males in 2022–2023, especially in extragenital/screening isolates. Median CIP MIC increased (0.003–0.0057 mg/L), most pronounced in male extragenital/screening isolates. CONCLUSION: Across the examined decade, NG showed subtle increases in MIC in extragenital/screening isolates from males, possibly reflecting decreasing antibiotic susceptibility in groups that regularly undergo STI screening. Rising AZM MIC suggests early spread of resistant strains. This highlights the need for continued surveillance, consistent susceptibility testing, targeted education for vulnerable groups, promotion of condom use, and potential vaccination.